8-K - Connect Biopharma Holdings Ltd - 7.01 / 8.01 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001835268-26-000016
Filing Date: 2026-04-23
Accepted: 2026-04-23 09:05:27
Documents: 12
Period of Report: 2026-04-23
Items: Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Connect Biopharma Holdings Ltd (Filer) CIK : 0001835268 (see all company filings) EIN. : 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40212 | Film No.: 26885848 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | cntb-20260423.htm iXBRL | 8-K
2 | EX-99.1 | exhibit991-seabreezeinteri.htm | EX-99.1
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cntb-20260423.xsd | EX-101.SCH
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cntb-20260423_lab.xml | EX-101.LAB